LendingClub Corp (LC) Stock News

The Rosen Law Firm is investigating potential securities claims against Barclays PLC following allegations of materially misleading business information. The investigation was triggered by Reuters reporting on February 27, 2026, that Barclays had a £600 million exposure to the collapsed UK mortgage lender Market Financial Solutions Ltd. Barclays' stock fell 3.99% on February 27 and 2.3% on March 2, 2026, following the news. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm has issued a deadline notice for a securities class action lawsuit against Lucid Group, Inc. The lawsuit alleges that defendants made false or misleading statements regarding supplier quality issues that significantly impacted Lucid Gravity production and the company's business results. Investors who purchased Lucid securities between February 25, 2026 and April 13, 2026 have until July 28, 2026 to join the class action.

Rosen Law Firm announces a July 28, 2026 deadline for investors to join a securities class action against Lucid Group, Inc. The lawsuit alleges that Lucid made false statements regarding supplier quality issues that disrupted Gravity deliveries and overstated manufacturing capabilities, resulting in material negative impact on the company's business and financial results.

A class action lawsuit has been filed against Erasca, Inc. alleging that the company made false and misleading statements regarding ERAS-0015's preclinical data, which was based on improper comparisons to Revolution Medicines and placed the company at risk of patent and trade secret violations. Investors who purchased Erasca securities between January 14, 2025 and April 26, 2026 are encouraged to join the case, with a lead plaintiff deadline of August 10, 2026.

A class action lawsuit has been filed against Embecta Corp. alleging that company executives made materially false and misleading statements about business operations and guidance during the Class Period (November 25, 2025 - May 4, 2026). The complaint claims Embecta misrepresented its pen needle business as 'incredibly resolute' before missing Q2 2026 guidance and cutting full-year guidance, with revenue declining over 14% versus guidance of flat to 2% decline.

A class action lawsuit has been filed against Badger Meter, Inc. alleging that the company made materially false and misleading statements regarding its financial results, demand environment, and growth prospects during the period from April 18, 2024 to April 16, 2026. Investors who purchased Badger Meter securities during this period are encouraged to join the case, with a lead plaintiff deadline of August 3, 2026.

A class action lawsuit has been filed against Globant S.A. alleging that the company made materially false and misleading statements regarding its Latin American operations. The complaint claims Globant's 'Latin American pivot' was unsuccessful, with the company experiencing declining demand, client defections, and project cancellations. Additionally, the company allegedly froze employee wages in Mexico and Argentina, contradicting claims of being a market leader and employer of choice in the region.

A class action lawsuit has been filed against PicS N.V. and its officers for alleged securities fraud in connection with its January 2026 IPO. The complaint alleges the company made materially false statements regarding credit evaluation procedures, misrepresented credit risk management effectiveness, and failed to disclose deteriorating customer credit quality and elevated default rates discovered in late 2025.

A class action lawsuit has been filed against AeroVironment, Inc. alleging that the company made materially false and misleading statements regarding its business prospects during the period from June 25, 2025 to March 10, 2026. The complaint claims AeroVironment understated competitive threats to its SCAR program work and overstated its financial prospects. Investors who suffered losses have until July 27, 2026 to request lead plaintiff status.

Monteverde & Associates PC is investigating four merger and acquisition transactions on behalf of shareholders. Pacific Financial Corporation is merging with Banner Corporation (0.2633 shares per share), Nuvalent Inc. is being acquired by GSK plc ($124.00 per share), Cross Country Healthcare is being sold to KL Criss Cross Intermediate LLC ($13.25 per share), and Bio Green Med Solution is merging with Future NRG Sdn. Bhd. Shareholders are encouraged to contact the firm regarding potential concerns with these transactions.

Holzer & Holzer, LLC announces lead plaintiff deadlines for shareholder class action lawsuits against three companies. Phreesia faces allegations of false statements regarding long-term growth outlook (deadline July 13, 2026). AeroVironment is accused of misrepresenting its competitive landscape (deadline July 27, 2026). Lucid Group faces claims about false statements regarding manufacturing and delivery capabilities (deadline July 28, 2026). Investors who purchased shares during the alleged fraud periods and suffered losses are encouraged to contact the firm.

Law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Gildan Activewear Inc. following a Jehoshaphat Research report alleging channel stuffing, revenue manipulation, and off-balance-sheet financial engineering. The allegations caused Gildan's stock to fall 18.8% on June 16, 2026. The firm is seeking investors who purchased Gildan securities to participate in the investigation.

A class action lawsuit has been filed against Microsoft Corporation alleging securities fraud. The complaint claims Microsoft made false statements by failing to disclose significant problems with its Copilot AI products, including poor benchmark performance, user experience issues, and failure to convert users to paid subscriptions. The lawsuit covers investors who purchased Microsoft securities between May 1, 2025 and January 28, 2026.

A class action lawsuit has been filed against ADMA Biologics, Inc. alleging securities fraud for the period between August 9, 2024 and March 25, 2026. The complaint claims the company engaged in undisclosed related party transactions, channel stuffing, and lacked adequate internal controls, resulting in materially false and misleading statements about its business operations and prospects.

A class action lawsuit has been filed against GRAIL, Inc. alleging that company executives made materially false and misleading statements regarding the NHS-Galleri trial's likelihood of success. The complaint claims defendants misrepresented the trial's prospects and concealed adverse data suggesting the three-year timeframe was insufficient to achieve the primary endpoint. Investors who purchased GRAIL securities between May 13, 2025 and February 19, 2026 are eligible to join the case.

Man Group PLC disclosed its interests in Senior Plc as of June 17, 2026. The disclosure shows Man Group holds 6,627,963 relevant securities representing 1.58% of Senior Plc, comprising 34,029 ordinary shares and 6,593,934 cash-settled derivatives. During the disclosure period, Man Group sold 38,344 ordinary shares at 2.8751 GBP per unit and reduced equity swap positions totaling 115,669 reference securities at the same price.

Burckhardt Compression has secured a major contract to supply compressor solutions for the first industrial-scale liquefied CO₂ (LCO₂) carrier, supporting the Northern Lights carbon capture and storage project. The order represents a significant step in scaling CCS from pilot applications to industrial deployment, enabling safe and efficient transport of captured emissions between industrial facilities and permanent storage sites across borders.

Abbott Cooper PLLC is investigating potential fiduciary duty violations by the Board of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) in connection with a private placement of preferred stock. The investigation targets stockholders who held shares prior to August 19, 2025.

Abbott Cooper PLLC is investigating potential fiduciary duty violations by the board of Indaptus Therapeutics in connection with a private placement of preferred stock. The investigation targets stockholders who held shares prior to December 22, 2025.

A class action lawsuit has been filed against Calix, Inc. alleging that the company failed to disclose that its first quarter margins benefited from advanced memory component purchases, that supplies were dwindling, and that it faced negative margin pressure from rising component costs. The lawsuit covers investors who purchased Calix securities between January 28, 2026 and April 21, 2026.

Sportradar Group AG faces a securities class action lawsuit for allegedly failing to disclose material information about working with black-market gambling operators and having inadequate Know-Your-Customer compliance processes, despite public claims of strict regulatory compliance. Investors who purchased shares between November 7, 2024 and April 21, 2026 can file lead plaintiff applications by July 17, 2026.

A securities class action lawsuit has been filed against SES AI Corporation for allegedly failing to disclose material information between January 29, 2025 and March 4, 2026. The company is accused of overstating business outlook, creating false revenue through self-dealing transactions, and concealing logistics constraints that impacted Q4 2025 results. The stock declined 37% following weaker-than-expected 2026 revenue guidance. Investors have until June 26, 2026 to file lead plaintiff applications.

A class action securities lawsuit has been filed against PicS N.V. for allegedly failing to disclose material information in its January 2026 IPO offering documents. The company is accused of concealing deficient credit assessment procedures, undisclosed Stage 3 formation rates exceeding 7%, overstated credit models, and deteriorating credit quality from expansion into riskier business lines. Investors who purchased shares in the IPO have until August 4, 2026 to request lead plaintiff status.

A securities class action lawsuit has been filed against Via Transportation, Inc. (NYSE: VIA) alleging that its September 2025 IPO registration documents contained materially misleading statements and omitted critical information about growth obstacles. The company was adding customers faster than they generated revenue, causing a decline in ARR per customer, and faced regulatory challenges in Germany. Via's stock has declined approximately 70% from its offering price to $14.52.

Zillow Group faces a securities class action lawsuit for allegedly failing to disclose material information about an agreement with Redfin that posed heightened antitrust risks. Investors who purchased Zillow stock between February 11, 2025 and May 7, 2026 can file lead plaintiff applications by August 10, 2026. The lawsuit claims Zillow misrepresented the nature of the Redfin deal and downplayed regulatory exposure.

GeneDx Holdings Corp. faces a securities fraud class action lawsuit for failing to disclose material information about its acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and disclosed a $31.2 million impairment loss on its Fabric Genomics acquisition. GeneDx shares fell 49.2% on May 4, 2026, following the disappointing financial results and lowered guidance.

A class action securities lawsuit has been filed against ADMA Biologics, Inc. for allegedly failing to disclose material information and making false statements. The complaint alleges undisclosed related party transactions, channel stuffing to inflate revenue, and inadequate internal controls. Investors who purchased securities between August 9, 2024 and March 25, 2026 may be eligible to participate, with an August 10, 2026 deadline to request lead plaintiff status.

A securities class action lawsuit has been filed against Activision Blizzard and certain board members for allegedly making materially false and misleading statements regarding the Microsoft merger. The lawsuit claims executives exploited sexual harassment allegations and regulatory investigations to engineer a hasty sale below internal valuation to lock in personal profits. Investors who sold Activision stock between January 18, 2022 and October 13, 2023 have until June 30, 2026 to file lead plaintiff applications.

A securities class action lawsuit has been filed against Lucid Group, Inc. for allegedly making false and misleading statements regarding supplier quality issues that disrupted Lucid Gravity deliveries and negatively impacted business results. Investors who purchased Lucid securities between February 25, 2026 and April 13, 2026 may be eligible for compensation. The lead plaintiff deadline is July 28, 2026.

Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.